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Background: Women with polycystic ovary syndrome (PCOS) have symptoms of depression and anxiety and
impaired health related quality of life (HRQoL). Here we test the post-hoc hypothesis that acupuncture and exercise
improve depression and anxiety symptoms and HRQoL in PCOS women.
Methods: Seventy-two PCOS women were randomly assigned to 16 weeks of 1) acupuncture (n = 28); 2) exercise
(n = 29); or 3) no intervention (control) (n = 15). Outcome measures included: change in Montgomery Åsberg
Depression Rating Scale (MADRS-S), Brief Scale for Anxiety (BSA-S), Swedish Short-Form 36 (SF-36), and PCOS
Questionnaire (PCOSQ) scores from baseline to after 16-week intervention, and to 16-week post-intervention
follow-up.
Results: A reduction in MADRS-S and BSA-S from baseline to 16-weeks post-intervention follow-up was observed
for the acupuncture group. The SF-36 domains role physical, energy/vitality, general health perception and the
mental component of summary scores improved in the acupuncture group after intervention and at follow-up.
Within the exercise group the role physical decreased after treatment, while physical functioning and general
health perception scores increased at follow-up. The emotion domain in the PCOSQ improved after 16-weeks of
intervention within all three groups, and at follow-up in acupuncture and exercise groups. At follow-up,
improvement in the infertility domain was observed within the exercise group.
Conclusion: There was a modest improvement in depression and anxiety scores in women treated with
acupuncture, and improved HRQoL scores were noted in both intervention groups. While not a primary focus of
the trial, these data suggest continued investigation of mental health outcomes in women treated for PCOS.
Trial registration number: ClinicalTrials.gov Identifier: NCT00484705
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Polycystic ovary syndrome (PCOS) is a complex endocrine
and metabolic disorder with an estimated prevalence of 8–
18% depending on diagnostic criteria [1]. The characteris-
tics of PCOS include polycystic ovaries, hyperandrogenism,
irregular menstrual cycles, and metabolic abnormalities* Correspondence: elisabet.stener-victorin@neuro.gu.se
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distribution, and reproduction in any mediumsuch as hyperinsulinemia and obesity [2]. PCOS adversely
affects health-related quality of life (HRQoL) [3-5] and
increases risk of depression and anxiety [6-13]. The recent
consensus report on women’s health aspects of PCOS
recommended that psychological issues be considered in
all women with PCOS, and highlighted the need for
development of appropriate interventions [14].
The management of PCOS is directed toward improv-
ing HRQoL by alleviating co-morbid psychiatric symp-
toms and preventing long-term physical and psychiatric
complications [4]. First line treatment of women withCentral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly cited.
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cise. In two studies, HRQoL measured by the polycystic
ovary syndrome questionnaire (PCOSQ) improved across
all domains after a lifestyle modification program [15,16].
In obese and overweight PCOS women, diet plus exercise
and diet alone decreased depression scores and improved
the PCOSQ domains of emotion, body weight, and
menstrual problems [17].
Acupuncture with manual stimulation [18,19] and elec-
trical stimulation of low-frequency, i.e. electro-acupuncture
has been shown to be effective in the treatment of major
depression disorder in women without PCOS [20-23], and
in women with depression during pregnancy [24,25] and
post partum [26]. In women with PCOS, both a standard-
ized acupuncture protocol with manual and electrical
stimulation of low-frequency and physical exercise has
been demonstrated to result in more regular menses and
decrease hyperandrogenemia [27]. Whether acupuncture
also improves symptoms of anxiety and depression and/or
HRQoL in these women has not been investigated. In
women with breast cancer, 12 weeks of acupuncture im-
proved HRQoL and sleep assessed with the Women’s
Health Questionnaire [28], general well-being assessed with
the Symptom Checklist and mood assessed with the Mood
Scale [29]. Similarly, acupuncture improved HRQoL
assessed by the short-form 36 (SF-36) in patients with
chronic pain conditions, such as dysmenorrhea [30] and
pain from osteoarthritis [31].
Trials of physical exercise for the treatment of depression
suggest that exercise is effective for decreasing depressive
symptoms, although one recent large randomized con-
trolled trials (RCT) reported no significant effect on
depressive symptoms [32,33].
Because PCOS is a chronic disease that is often
accompanied by symptoms of anxiety and depression
and impaired HRQoL, with health implications across
the lifespan, there is a need to evaluate treatment
options that have few negative side effects, such as
acupuncture and physical exercise. In this study, we
tested the secondary hypothesis that affective symptoms
and impaired HRQoL can be improved by acupuncture
and physical exercise in women with PCOS.Methods
Study design
The study is a secondary analysis of a prospective random-
ized clinical trial (RCT) [27] in women with PCOS. All
participants were Swedish women living in Gothenburg.
The study was conducted at Sahlgrenska Academy at
the University of Gothenburg, performed in accordance
with Declaration of Helsinki, and approved by the Ethics
Committee at the University of Gothenburg. The Clinical
Trials Government Identifier number is NCT00484705.All participants gave written informed consent before
entering the study.
Recruitment and participants
PCOS cases were recruited between November 2005
and January 2008 by newspaper advertisements in the
local community. Eligible participants had ultrasound-
verified (HDI 5000, ATL, Bothell, WA) polycystic ovaries
with at least 12 follicles 2–9 mm and/or an ovarian
volume ≥10 ml in one or both ovaries, together with
oligo/amenorrhea and/or clinical signs of hyperandro-
genism. Hyperandrogenism was defined as either;
hirsutism with a Ferriman Gallwey (FG) score ≥8, and/or
the presence of acne as defined by responding ‘yes’ to the
question, Do you have acne? together with circulating total
testosterone ≥ 1.8 nmol/L [34]. Oligomenorrhea was
defined as an intermenstrual interval >35 days and fewer
than eight menstrual bleedings in the past year.
Amenorrhea was defined as no menstrual bleeding in the
past 90 days.
Exclusion criteria were: age ≥38 years, any pharmaco-
logical treatment for PCOS within 12 weeks of study
entry, or breast feeding within 24 weeks of study entry.
Other exclusion criteria were cardiovascular disease,
type 2 diabetes, and endocrine or neoplastic causes of
hyperandrogenemia, including androgen-secreting tu-
mors, Cushing’s syndrome, congenital adrenal hyperpla-
sia, and hyperprolactinaemia. In the RCT, women were
randomly allocated in a 2:2:1 ratio to low-frequency EA,
physical exercise, or no active intervention (control). A
2:2:1 ratio was used to facilitate recruitment. To ensure
equal proportions of age and BMI in each study arm,
randomization was stratified by those variables. Within
each stratum, randomization was accomplished by
computer using permuted blocks of 5. Based on the
aforementioned inclusion and exclusion criteria, the final
study population was comprised of 72 PCOS women who
were assessed at baseline, followed by randomization to
acupuncture (n = 28), physical exercise (n = 29), or no
intervention (n = 15) for 16 weeks [27].
Outcome measures
Questionnaires were completed at baseline, after the 16-
week treatment, and 16 weeks after the last treatment.
The outcome measure assessing symptoms of depression
and anxiety was the CPRS-S-A [35], from which the
subscales Montgomery Åsberg Depression Rating Scale
(MADRS-S) [36] and the Brief Scale for Anxiety (BSA-S)
[37] were extracted. MADRS-S and BSA-S each include
9 items, of which two are present in both scales. All
items are rated on a 7-point Likert scale, where 0
indicates no symptoms and 6 an extremely pathological
condition. Item ratings are summed, yielding a max-
imum value of 54 for each scale. A symptom burden
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total ≥11 on each scale [10].
The outcome measures to assess HRQoL were the
generic SF-36 [38] and the disease-specific Polycystic
Ovary Syndrome Questionnaire (PCOSQ) [39,40]. SF-36
has 36 items, of which 35 are grouped into eight do-
mains: 1) physical function, 2) role physical, 3) role emo-
tional, 4) social functioning, 5) mental health, 6) energy/
vitality, 7) bodily pain, and 8) the experience of change
in general health during the last year. The eight domains
are scored from 0 (worst health) to 100 (best health).
The Swedish version of the PCOSQ has been demon-
strated to be valid and reliable [40]. It consists of 26
items grouped into five domains: emotions, body hair,
weight concerns, infertility concerns, and menstrual
irregularities. Each item is rated on a 7-point Likert
scale, from 1 (poorest function) to 7 (optimal function).Interventions
The acupuncture treatment and physical exercise inter-
ventions have been described in detail [27]. In brief, all
participants received general information about the ben-
efits of regular exercise and were instructed to complete
a physical exercise diary during weeks 1–32 of the study.Acupuncture intervention
Acupuncture was given twice weekly for 2 weeks, once
weekly for 6 weeks, and once every other week for
8 weeks (14 treatments over 16 weeks). Acupuncture
was performed by a registered physical therapist
educated in theoretical and practical acupuncture skills.
Acupuncture points and electrical stimulation were the
same for all women in the acupuncture group. Dispos-
able, single-use, sterilized stainless-steel needles (Hegu
Xeno, Hegu, Landsbro, Sweden; length 30/50 mm, diam-
eter 0.32 mm) were inserted to a depth of 15–35 mm in
four acupuncture points in abdominal muscles and four
in the muscles below the knee, bilaterally. All points in
somatic segments corresponded to the innervation of
the ovaries (Th12–L2, S2–S4). Two needles were also
placed in extrasegmental acupuncture points that do not
innervate the ovaries (muscles in the hand and lower
arm, bilaterally) to enhance central nervous system
effects. All needles were stimulated manually once when
inserted. During each treatment, needles in abdominal
and leg muscles were stimulated electrically with low-
frequency (2 Hz) (CEFAR ACUS 4, Cefar-Compex
Scandinavia, Malmö, Sweden) for 30 min. The intensity
was adjusted to produce local muscle contractions
without pain or discomfort. Needles in the hand/lower
arm were stimulated manually by rotating the needle to
evoke needle sensation every 10 min.Physical exercise intervention
The physical exercise program consisted of 16 weeks of
regular exercise, including brisk walking, cycling, or any
other aerobic exercise at a self-selected pace described
as “faster than normal walking” that could be sustained
for at least 30 min at least 3 days per week according to
the protocol by Randeva et al. [41]. Physical exercise
was self-monitored with a heart rate monitor (ECG2,
Sports Instruments, US) to ensure a heart rate ≥120
beats/min. After the initial instructions of exercise,
participants did not receive any direct contact with the
investigators except that they were supervised through
weekly telephone calls to provide guidance on how to
increase physical exercise. All exercise was in addition
to usual daily physical activity.
Controls
Like the other participants, women in the no interven-
tion group received oral information about the benefits
of regular physical exercise. All participants could call
the study coordinator at any time.
Statistical analyses
Values are presented as mean ± SD. All scores were
treated as ordinal variables and assessed with nonpara-
metric statistical tests. Sample size calculations for the
RCT have been described previously [27]. Data were
analyzed according to the intention to treat principle.
Missing data were replaced by carrying forward the last
observation to evaluate changes over baseline to after
16-week intervention, and to 16-week post-intervention
follow-up i.e. 32 weeks.
Between group differences in MADRS-S, BSA-S, SF-36
and PCOSQ scores from baseline to after 16-week inter-
vention, and to 16-week post-intervention follow-up were
analyzed with the Kruskal-Wallis test followed by the
Mann–Whitney U test. Potential within group changes
(baseline versus week 16 and baseline versus week 32)
were analyzed with the Wilcoxon signed-rank test.
IBM SPSS Statistics version 19 for Windows (SPSS,
Chicago, IL) was used for statistical analyses; P < 0.05
(two-sided) was considered statistically significant.
Results
Table 1 shows anthropometry and scores on PCOSQ
domains for all participants. There were no differences
in anthropometric measurements before and after
treatment, as reported [27].
Symptoms of depression and anxiety. There were no
baseline differences between the groups regarding
anxiety and depression scores; MADRS-S and BSA-S
(Table 2). Over the 16 week intervention, there was
neither within group differences nor between group
differences regarding change in MADRS-S or BSA-S
Table 1 Anthropometry and PCOSQ domains of women
with polycystic ovary syndrome
PCOS (n = 72)
Anthropometry
Age (years) 29.9 ± 4.4
BMI (kg/m2) 28.1 ± 7.4
WHR 0.84 ± 0.07
PCOSQ
Emotions 4.4 ± 1.2
Body hair 3.4 ± 2.0
Body weight 3.6 ± 2.0
Infertility 4.0 ± 1.7
Menstruation 4.0 ± 1.1
Values are mean ± SD. BMI, body mass index; WHR, waist hip ratio; PCOSQ,
polycystic ovary syndrome questionnaire.
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significantly lower in the acupuncture group (Table 4).
No change was observed between baseline and week 32
in MADRS score was observed in the exercise group at
week 32. The BSA-S score was significantly lower within
the acupuncture group at week 32 and differed from that
in the exercise group but not the control group (Table 4).
Although there was no within group change in theTable 2 Baseline characteristics
Acupuncture (n = 28) Physic
Depression & Anxiety scores
MADRS-S sum total 10.7 ± 6.2 10.8 ±
BSA-S sum total 13.1 ± 6.4 11.3 ±
SF36 domains
Physical functioning 88.6 ± 16.4 87.9 ±
Role physical 67.9 ± 33.9 86.2 ±
Role emotional 52.4 ± 43.9 47.1 ±
Social functioning 74.6 ± 21.6 67.2 ±
Mental health 60.3 ± 19.5 60.3 ±
Energy/vitality 44.3 ± 22.0 48.8 ±
Bodily pain 73.4 ± 19.4 71.9 ±
General health perception 56.6 ± 25.2 63.7 ±
SF36 summary scores
Physical component summary 50.1 ± 9.8 53.1 ±
Mental component summary 35.7 ± 14.2 33.8 ±
PCOSQ
Emotions 4.7 ± 1.2 4.2 ± 1
Body hair 4.0 ± 2.2 2.9 ± 1
Body weight 4.1 ± 2.2 3.3 ± 2
Infertility 4.2 ± 1.7 3.6 ± 1
Menstruation 4.1 ± 0.9 3.9 ± 1
Values are mean ± SD. Between-group differences at baseline were determined witexercise group, the BSA-S score differed from that in the
control group at week 32 (Table 4).
HRQoL. There were no baseline differences between
the groups regarding HRQoL; SF-36 and PCOSQ scores
(Table 2). Between baseline and week 16, the SF-36
domain role physical score increased within the acupunc-
ture group and the delta change differed from that in the
exercise group which had decreased but not the control
group (Table 3). The SF-36 domains social functioning,
energy/vitality, general health perception and the mental
component summary score increased within the acu-
puncture group between baseline and week 16, although
there were no between group differences. Between base-
line and follow up, the SF-36 domains role physical,
energy/vitality, general health perception and the mental
component summary score increased within the
acupuncture group, with no between group differences
(Table 4).
Within the physical exercise group the physical func-
tioning score was higher at week 32 compared to baseline,
and delta change differed from that in the acupuncture
and control groups (Table 4). The general health percep-
tion score increased within the exercise intervention
group. Within the control group, role emotional score was
greater at week 32 compared to baseline.al exercise (n = 29) Control (n = 15) P Between group
9.0 13.8 ± 9.4 ns
6.0 14.6 ± 5.7 ns
15.0 92.3 ± 10.0 ns
22.7 76.7 ± 30.6 ns
42.3 37.8 ± 41.5 ns
26.2 67.5 ± 31.3 ns
19.9 56.0 ± 23.1 ns
23.9 46.6 ± 19.2 ns
32.6 72.9 ± 23.5 ns
18.0 64.6 ± 18.6 ns
7.4 54.4 ± 6.1 ns
12.9 30.8 ± 15.2 ns
.1 4.2 ± 1.2 ns
.9 3.3 ± 1.9 ns
.0 3.1 ± 1.7 ns
.6 4.5 ± 1.6 ns
.2 4.0 ± 1.4 ns
h the Kruskal-Wallis test.
Table 3 Changes in outcome measures from baseline to week 16 directly after treatment
Acupuncture (n = 28) Physical exercise (n = 29) Control (n = 15) P*
Mean ± SD Δ% Mean ± SD Δ% Mean ± SD Δ%
Depression & Anxiety scores
MADRS-S sum total −0.96 ± 5.25 −9.0 0.52 ± 7.62 4.8 1.53 ± 5.33 11.1 ns
BSA-S sum total −1.61 ± 4.72 −12.3 0.41 ± 5.62 3.6 −0.13 ± 3.96 −0.9 ns
SF-36 domains
Physical functioning −1.7 ± 12.9 −1.9 0.9 ± 10.2 1.0 −4.0 ± 8.1 −4.3 ns
Role physical 8.0 ± 31.2A,a 11.8 −16.4 ± 36.8d −19.0 −6.7 ± 27.5 −8.7 0.046
Role emotional 6.5 ± 35.8 12.4 5.7 ± 45.5 12.1 15.6 ± 35.3 41.3 ns
Social functioning 8.0 ± 17.7 a 10.7 3.0 ± 23.1 4.5 −3.3 ± 18.0 −4.9 ns
Mental health 5.7 ± 16.0 9.5 −1.1 ± 19.8 −1.8 −4.5 ± 13.7 −8.0 ns
Energy/vitality 8.4 ± 16.9 b 19.0 0.7 ± 16.8 1.4 −1.2 ± 16.4 −2.6 ns
Bodily pain 2.2 ± 21.2 3.0 1.3 ± 30.2 1.8 −3.0 ± 19.7 −4.1 ns
General health perception 5.9 ± 13.6a 10.4 1.2 ± 11.6 1.9 −5.5 ± 16.8 −8.5 ns
SF-36 summary scores
Physical component 0.4 ± 6.4 0.8 −1.6 ± 6.2 −3.0 −3.2 ± 4.6 −5.9 ns
Mental component 4.3 ± 9.7b 12.0 1.6 ± 10.5 4.7 1.5 ± 9.2 4.9 ns
PCOSQ domains
Emotions 0.8 ± 0.8c 17.0 0.8 ± 1.2e 19.0 0.7 ± 0.7g 16.7 ns
Body hair −0.1 ± 0.8 −2.5 0.1 ± 0.6 3.4 0.2 ± 1.1 6.1 ns
Body weight 0.2 ± 0.5 4.9 0.1 ± 1.1 3.0 0.6 ± 1.0 f 19.4 ns
Infertility 0.3 ± 1.0 7.1 0.4 ± 1.0d 11.1 0.0 ± 0.7 0.0 ns
Menstruation 0.4 ± 1.0 9.8 0.4 ± 1.0 10.3 0.4 ± 0.8f 10.0 ns
*Intergroup differences for the changes from baseline to week 16 were determined by the Kruskal-Wallis test followed by Mann–Whitney U-test: AP < 0.05 vs
physical exercise. Within group changes were determined by Wilcoxon rank-sum test: aP < 0.05 (acupuncture group); bP < 0.01 (acupuncture group); cP < 0.001
(acupuncture group); dP < 0.05 (exercise group); eP < 0.001 (exercise group); fP < 0.05 (control group); gP < 0.001 (control group).
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change between baseline and week 16 in any of the five
PCOSQ domains (Table 3). The emotions domain in-
creased significantly within all three groups between
baseline and week 16; the infertility domain increased
within the exercise group, and the body weight and
menstruation domains increased within the control
group (Table 3).
At 32 week follow-up, improvement in the infertility
domain was observed within the exercise group and
delta change differed from that in the control group
(Table 4). The emotion domain was higher at week 32
compared to baseline within the acupuncture and
exercise groups, and the body weight domain was higher
in the control group at week 32 compared to baseline.
Discussion
This is the first study to evaluate the effect of acupuncture
on affective symptoms and HRQoL in women with PCOS.
We demonstrated a within group reduction in depression
and anxiety scores at follow up 16 weeks after the last
treatment. HRQoL was greater in the acupuncture group,
as reflected by increased scores in the SF-36 domain rolephysical after a 16 week intervention. In addition, the SF-
36 domains social functioning, energy/vitality, and general
health perception and the mental component of SF-36
summary scores improved within the acupuncture group
although there were no between-group differences. The
effect remained at 32 weeks follow-up in the domain roles
physical, energy/vitality, and general health perception and
in the mental component of SF-36 summary scores. The
emotion domain in the PCOSQ also improved signifi-
cantly after the 16 week acupuncture intervention, which
persisted at 32 weeks.
The results in the present study are in line with previous
reports indicating that acupuncture can reduce symptoms
of anxiety [42] and depression [22,23,25] and improve
HRQoL [28,30,31] in other conditions than PCOS. The
effect of acupuncture was more pronounced on anxiety
symptoms and there was a clear tendency of decrease
within the acupuncture group immediately after the treat-
ment period but it did not reach statistical significance. At
the follow up, the decrease was even larger and decreased
symptoms of anxiety as compared to the exercise group.
This may reflect that the effect of treatment last at least
4 months after the treatment period.
Table 4 Changes in outcome measures from baseline to follow-up week 32
Outcome measure Acupuncture (n = 28) Physical exercise (n = 29) Control (n = 15) P*
Mean ± SD Δ% Mean ± SD Δ% Mean ± SD Δ%
Depression & Anxiety scores
MADRS-S sum total −1.00 ± 8.07 a −9.3 0.55 ± 8.00 5.1 1.00 ± 6.94 7.2 ns
BSA-S sum total −1.74 ± 7.88 A,a −13.3 1.41 ± 6.86 B 12.5 −1.53 ± 3.78 −10.5 0.027
SF-36 domains
Physical functioning −2.5 ± 17.4 −2.8 3.8 ± 6.7 C,d 4.3 −3.7 ± 7.4 −4.0 0.008
Role physical 12.5 ± 33.7a 18.4 −0.9 ± 19.5 −1.0 −6.7 ± 27.5 −8.7 ns
Role emotional 11.9 ± 40.8 22.7 17.2 ± 42.4 36.5 22.2 ±34.9 f 58.7 ns
Social functioning 5.8 ± 20.5 7.8 5.2 ± 25.3 7.7 2.5 ± 21.2 3.7 ns
Mental health 6.3 ± 19.5 10.4 4.1 ± 20.0 6.8 −4.3 ± 21.9 −7.7 ns
Energy/vitality 11.3 ± 17.0b 25.5 5.5 ± 20.5 11.3 −4.2 ± 18.3 −9.0 ns
Bodily pain 2.8 ± 20.6 3.8 3.6 ± 30.0 5.0 0.3 ± 15.8 0.4 ns
General health perceptions 6.8 ± 16.0a 12.0 5.3 ± 10.0 c 8.3 −4.6 ± 19.2 −7.1 ns
SF-36 summary scores
Physical component summary 0.5 ± 7.9 1.0 0.2 ± 5.2 0.4 −1.7 ± 5.1 −3.1 ns
Mental component summary 5.1 ± 12.4a 14.3 4.3 ± 11.6 12.7 1.8 ± 11.6 5.8 ns
PCOSQ domains
Emotions 0.4 ± 0.8a 8.5 0.6 ± 1.0 d 14.3 0.1 ± 0.7 2.4 ns
Body hair −0.1 ± 0.9 −2.5 0.1 ± 0.8 3.4 −0.2 ± 0.8 −6.1 ns
Body weight 0.2 ± 0.8 4.9 0.2 ± 1.2 6.1 0.4 ± 0.8 f 12.9 ns
Infertility 0.2 ± 1.1 4.8 0.6 ± 1.2 B,d 16.7 −0.1 ± 0.8 −2.2 0.014
Menstruation 0.3 ± 1.0 7.3 −0.1 ± 1.0 −2.6 −0.5 ± 1.0 −12.5 ns
*Intergroup differences for the changes from baseline to week 16 were determined by the Kruskal-Wallis test followed by Mann–Whitney U-test: AP < 0.05 vs
physical exercise; BP < 0.05 vs control group; CP < 0.05 vs EA and control group. Within group changes were determined by Wilcoxon rank-sum test: aP < 0.05
(acupuncture group); bP < 0.01 (acupuncture group); cP < 0.05 (exercise group); dP < 0.01 (exercise group); eP < 0.001 (exercise group); fP < 0.05 (control group).
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was designed to improve reproductive and endocrine
function. Accordingly, needles were placed in abdominal
and leg muscles with the same innervation as the ovar-
ies. Additionally two points, one in each hand was
placed. Points in arm/hand and leg/feet are considered
to have a strong input to central nervous system [43]. If
the primary aim of this study would have been to eluci-
date the efficacy of acupuncture on symptoms of anxiety
and depression and HRQoL, the acupuncture protocol
would have been the same but with additional points in
the head, e.g. EX1 and GV20 and stimulated electrically
since these points has been shown to relive symptoms of
depression [22,23,25].
There was no effect on symptoms of anxiety and de-
pression in the exercise group, while the SF-36 domain
physical functioning score and the PCOSQ domain
infertility improved at the 16-week follow-up compared
with the control group. Directly after the treatment
period, the exercise group improved in the PCOSQ do-
mains emotion and infertility scores. The improvement
in the infertility score in the exercise group may reflect
an effect on menstrual function. In the primary study[27], the menstrual function was increased both after the
treatment and at follow up which most likely reflect
improved infertility score on PCOSQ.
A lifestyle program, including dietary intervention
leading to considerable weight loss, has been shown to
induce major improvement in HRQoL in patients with
type 2 diabetes, and the addition of exercise was import-
ant for maintaining better HRQoL [44]. However, studies
of lifestyle intervention in women with PCOS have not
shown that exercise reduces symptoms of anxiety and
depression and HRQoL beyond the reductions observed
after dietary intervention and weight loss [15,17].
Evidently, weight loss is an important predictor of im-
provement in affective symptoms and HRQoL. However,
the effect on HRQoL in the current study cannot be
attributed to weight reduction as there were no changes
in weight or BMI [27].
A recent systematic review found strong evidence that
exercise reduces depressive symptoms among patients
with chronic illness [45]. However, recently a large RCT
including 361 adults with symptoms of depression found
no effect of physical activity including three face to face
sessions and 10 telephone calls over eight months [33].
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present study may reflect that exercise was self-directed
but with telephone support. Again, these findings indicate
the need for further research on the effects of exercise in
women with PCOS. Structured, supervised exercise
may improve affective symptoms and HRQoL and is
recommended in future studies.
The PCOSQ domains, emotions, body weight, and
menstruation were higher in the control group after
treatment, and the body weight domain persisted higher
at the week 32 follow-up. These results suggest that
merely entering a study and being examined is positive.
Importantly, information on the benefits of regular
physical exercise and information about their condition
that may have made them feel less different and/or
increased their understanding of their health concerns,
was provided to all women at the baseline visit.
Methodological considerations
A strength of this study is the randomized design. How-
ever, it was also limited by the multiple comparisons and
characteristics of the study design, as extensively discussed
elsewhere [27,46]. Importantly, the results presented in
this paper stem from a secondary analysis; the study was
not designed or powered to specifically address these
research questions. We suggest that future RCTs for
women with PCOS include assessments of anxiety and
depression symptoms and HRQoL to elucidate the impact
of any intervention on these variables.
Conclusions
In conclusion, there was a modest improvement in
depression and anxiety scores in women treated with
acupuncture, and improved HRQoL scores were noted
in both intervention groups. Acupuncture and physical
exercise are well-tolerated and safe. While not a primary
focus of the clinical trial, these data suggest continued
investigation of mental health outcomes in women
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